Pregnancy Rewrites the Maternal Microbiome, and Dysbiosis Can Derail It

Pregnancy is not just a hormonal event; it is a microbial one. Across nine months, the communities of bacteria living in a woman's gut, vagina, and mouth shift in coordinated ways that support fetal growth, calibrate the maternal immune system, and prepare the body for birth. A new literature review published in Life synthesizes what researchers now know about those shifts, and it paints a picture in which the line between healthy adaptation and harmful dysbiosis is surprisingly thin.

Vaginal Lactobacillus loss and its link to preterm birth

A healthy vaginal microbiome during pregnancy is dominated by Lactobacillus species, which keep vaginal pH low and suppress pathogenic bacteria. When that dominance collapses, a state called vaginal dysbiosis, the protective barrier weakens. The review associates this loss of Lactobacillus with intrauterine infection and preterm birth, two outcomes that together account for significant neonatal morbidity worldwide. Estrogen and progesterone, both elevated during pregnancy, influence bacterial metabolism and the virulence of pathogenic bacteria, making hormonal change itself a driver of microbial risk. Broader research on microbiome-host interactions during pregnancy has similarly flagged the vaginal site as particularly sensitive to hormonal flux, with disruption at this site carrying outsized consequences for birth timing.

How gut microbial shifts across trimesters can trigger gestational diabetes and preeclampsia

The gut microbiome undergoes its own trimester-specific remodeling. By the third trimester, butyrate-producing bacteria decline and proteobacteria increase, a pattern that enhances intestinal permeability, sometimes called "leaky gut." The review notes that butyrate-producing bacteria levels inversely correlate with systolic and diastolic blood pressure, as well as with plasminogen activator inhibitor-1 (PAI-1), a clotting marker elevated in overweight and obese pregnant women. This metabolic cascade is associated with gestational diabetes mellitus and preeclampsia. Obesity compounds the risk: pregnant women with higher body mass show elevated levels of Bacteroides and Staphylococcus, along with altered pro-inflammatory cytokines, a microbial signature that may contribute to pathological gut changes early in pregnancy and, in turn, to preeclampsia. The gut microbiota also progressively shifts toward a Firmicutes-dominant profile across gestation, a composition the review describes as similar to that seen in obese populations generally.

Oral dysbiosis and periodontal disease as underappreciated pregnancy hazards

The mouth is the human body's second most complex microbial environment, and pregnancy changes it too. Gingival inflammation and periodontitis, which worsen with the hormonal shifts of gestation, are associated with low birth weight and premature birth, likely through systemic inflammation that reaches the placenta. This oral-systemic link is often overlooked in prenatal care, yet the review positions it alongside vaginal and gut dysbiosis as a meaningful contributor to adverse outcomes. Maternal microbiome dysbiosis has been linked to adverse outcomes across maternal and infant health, with inflammation and oxidative stress serving as shared mechanistic threads across all three microbial sites.

Offspring neurodevelopment, ASD, and the limits of what we can conclude

Perhaps the most striking section of the review concerns the developing fetus. The maternal gut microbiome, through metabolites, immune signals, and possibly direct microbial transfer, appears to influence fetal neurodevelopment and immune programming. Maternal immune activation arising from intestinal dysbiosis is associated with elevated risks for autism spectrum disorder, ADHD, and cognitive impairment in children. Stress, infection, and antibiotic use during pregnancy can each induce dysbiosis and, the evidence suggests, may increase neurodevelopmental risk in offspring. A critical review of the maternal microbiome's influence on offspring neurodevelopment notes ongoing controversy about whether prenatal microbial programming is causal or correlational, and that debate applies here too. The review in Life is careful to frame these findings as associations rather than proven mechanisms, which is the scientifically honest position given where the field stands.

Distinguishing normal, adaptive microbial remodeling from actual dysbiosis remains one of the field's central unsolved problems. Methodological challenges in neonatal microbiome research compound the difficulty: cohort designs vary, sample sizes are often small, and confounders like diet, antibiotic exposure, and socioeconomic status are rarely controlled consistently. The specific mechanisms by which maternal gut microbes affect offspring intestinal integrity and central nervous system imprinting also remain incompletely understood. Robust longitudinal study designs that track maternal and infant microbiota across pregnancy and postpartum are beginning to fill this gap, but findings from those cohorts are still maturing.

Probiotic and dietary interventions as a next frontier for maternal care

The review closes on a cautiously optimistic note. Personalized microbiome-based strategies, including dietary shifts toward fiber-rich foods that feed beneficial bacteria and targeted probiotic supplementation, show therapeutic promise for reducing dysbiosis risk. The pipeline of maternal gut microbiome interventions is growing, with probiotics attracting the most clinical attention, though no specific treatments have yet reached routine recommendation status. The authors call for well-designed longitudinal and multicentric studies that integrate maternal, neonatal, and environmental microbiota data, the kind of comprehensive evidence base that would let clinicians move from association to intervention with confidence. Until that evidence arrives, the practical takeaway is that the microbial health of a pregnant woman is not incidental to her pregnancy: it is part of the pregnancy itself, with consequences that may echo into her child's first years of life.

Evidence rating

EMERGING — 80/100

Caveats:

• This is a narrative literature review, not an original study — it synthesizes existing research and cannot establish causation on its own.
• Distinguishing normal, adaptive microbial changes in pregnancy from true dysbiosis remains an unsolved methodological challenge in the field.
• Many of the underlying studies are observational, meaning the associations reported do not confirm that microbiome changes directly cause the outcomes described.
• Funding source was not disclosed by the authors.

Narrative literature review synthesizing research across vaginal, gut, and oral microbiome changes during pregnancy. Findings are drawn from predominantly observational and cross-sectional studies, so reported associations between dysbiosis and outcomes such as preterm birth, gestational diabetes, and fetal neurodevelopmental risk do not establish causation. Several key mechanistic questions — including the precise role of gut dysbiosis in preterm birth and the existence of a placental microbiome — remain unresolved and await well-powered longitudinal studies.

References

1. Lucia Maria Procopciuc, Gabriela Valentina Caracostea, Adriana Corina Hangan, Roxana Liana Lucaciu (2026). The Maternal Microbiome in Pregnancy: From Physiological Changes to Dysbiosis and Obstetrical Complications—Therapeutic Perspectives. Life. https://doi.org/10.3390/life16061033
2. Zain Zaki Zakaria, Shouq Al-Rumaihi, Rana S. Al-Absi, et al. (2022). Physiological Changes and Interactions Between Microbiome and the Host During Pregnancy. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2022.824925
3. Umer Ahmed, Furrmein Fatima, Hafiza Amna Farooq (2025). Microbial dysbiosis and associated disease mechanisms in maternal and child health. Infection and Immunity. https://doi.org/10.1128/iai.00179-25
4. Hua Bai, Yan Xu, Shen Qu, Borui Li, Xinna Wang (2026). The influence of the maternal microbiome on offspring neurodevelopment: a critical review of associations, controversies, and challenges. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2025.1737795
5. Jonathan A Chapman, Christopher J Stewart (2023). Methodological challenges in neonatal microbiome research. Gut Microbes. https://doi.org/10.1080/19490976.2023.2183687
6. Daniella Susic, Gregory Davis, Anthony J O' Sullivan, et al. (2020). Microbiome Understanding in Maternity Study (MUMS), an Australian prospective longitudinal cohort study of maternal and infant microbiota: study protocol. BMJ Open. https://doi.org/10.1136/bmjopen-2020-040189
7. Kate Mills, Joelle Tan, Tahlia Guneratne, et al. (2025). Maternal gut microbiome interventions to improve maternal and perinatal health outcomes: Target product profile expert consensus and pipeline analysis. PLOS One. https://doi.org/10.1371/journal.pone.0321543